Review of the concept of «sufficiency and insufficiency» of vitamin D;Revisión del concepto de «sufficiency and insufficiency» de vitamina D

Nefrologia

Volumn 23, Issue SUPPL.2, 2003, Pages 73-77

  Gómez Alonso, Carlos ^a   Naves Diaz M ^a   Rodriguez Garcia M ^a   Fernandez Martin J L ^a   Cannata Andia J B ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

25 hydroxyvitamin D; Calcitriol; Chronic kidney; Hyperparathyroidism

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CREATININE; PARATHYROID HORMONE; VITAMIN D;

AGED; BLOOD; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; NUTRITIONAL REQUIREMENT; OSMOLARITY; OSTEOMALACIA; OSTEOPOROSIS; PHYSIOLOGY; PREVALENCE; RANDOMIZATION; REFERENCE VALUE; REVIEW; SECONDARY HYPERPARATHYROIDISM; SPAIN; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; CALCIFEDIOL; CALCITRIOL; CREATININE; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; NUTRITIONAL REQUIREMENTS; OSMOLAR CONCENTRATION; OSTEOMALACIA; OSTEOPOROSIS; PARATHYROID HORMONE; PREVALENCE; RANDOM ALLOCATION; REFERENCE VALUES; SAMPLING STUDIES; SPAIN; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 0038334298     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A. Vitamin D metabolism and action. Osteoporos Int 8 (Supl. 2): S13-9, 1998.
2. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93: 69-77, 1992.
3. Vieth R. Problems with direct 25-hydroxyvitamin D assays, and the target amount of vitamin D nutrition desirable for patients with osteoporosis. Osteoporos Int 11: 635-636, 2000.
4. Lips P, Chapuy MC, Dawson-Hughes B, Pols HA, Holick MF. An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int 9: 394-397, 1999.
5. Ringe JD. Vitamin D Deficiency and Osteopathies. Osteoporos Int 8: S35-S39, 1998.
6. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69: 842-56, 1999.
7. Scharla SH. Prevalence of Subclinical Vitamin D Deficiency in Different European Countries. Osteoporos Int 8: S7-S12, 1998.
8. Van der Wielen RP, Lowik MR, Van den Berg H, De Groot LC, Haller J, Moreiras O, Van Staveren WA. Serum vitamin D concentrations among elderly people in Europe. Lancet 346: 207-210, 1995.
9. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 15: 1113-8, 2000.
10. McKenna MJ, Freaney R. Secondary Hyperparathyroidism in the Elderly: means to Defining Hypovitaminosis D. Osteoporos Int 8: S3-S6, 1998.
11. Gómez-Alonso C, Naves-Díaz ML, Fernández-Martín JL, Díaz-López JB, Fernández-Coto M, Cannata-Andía JB. Vitamin D status and secondary hyperparthiroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int 2003 (in press).
12. Cannata-Andía JB, Gómez Alonso C. Vitamin D deficiency: a neglected aspect of disturbed calcium metabolism in renal failure. Nephrol Dial Tranpl 17: 1-4, 2002.
13. Cunningham J, Makin H. How important is vitamin D deficiency in uraemia? Nephrol Dial Transplant 12: 16-8, 1997.
14. Fournier A, Fardellone P, Achard JM, Ghazali A, Pruna A, El Esper N, Moriniere P. Importance of vitamin D repletion in uraemia. Nephrol Dial Transplant 14: 819-23, 1999.
15. Ghazali A, Fardellone P, Pruna A et al. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int 55: 2169-2177, 1999.
16. Heaney RP. Vitamin D: How much do we need, and how much is too much? Osteoporos Int 11: 553-555, 2000.